Core Insights - China Feihe held its 2025 Partner Conference in Wuhan, focusing on high-quality development in the dairy industry and emphasizing the company's commitment to innovation and collaboration with partners [1][3][17] Industry Overview - The overall mother and baby market is stabilizing, with significant growth in the ultra-premium segment, driven by consumption upgrades and supportive fertility policies [3][5] - China remains the largest infant formula market globally, with steady release of consumption potential [3] Company Achievements - Feihe has established itself as a market leader by pioneering the first complete industrial chain in the infant formula sector in 2006 and leading various innovations, including the "Fresh Nutrition System" [5][9] - The company has achieved 100% self-supply capability for 11 key nutrients and is the first in the industry to implement raw material traceability [9][11] Strategic Direction - Feihe's "New Generation More Suitable" strategy aims to address evolving consumer needs and enhance product quality across the entire supply chain [7][9] - The company plans to launch new products that significantly improve nutrient absorption and cognitive development for infants [9][11] Collaborative Ecosystem - Feihe emphasizes a collaborative approach with partners, recognizing their contributions to expanding channels, marketing innovations, and service upgrades [5][15] - The company has accelerated its international expansion, securing a production license in Canada and increasing its presence in North America and Southeast Asia [15][16] Future Outlook - Feihe aims to continue enhancing its product offerings across all life stages, focusing on adult nutrition and functional products, while also expanding its market reach [15][16][17]

Core Insights - The event on October 14 highlighted the launch of Feihe's new generation of infant formula, emphasizing its suitability for Chinese babies' physical constitution [1] - The initiative is backed by significant research collaborations and aims to closely mimic the nutritional profile of breast milk [2][5] Group 1: Research and Development - Feihe's strategy is rooted in understanding the unique properties of breast milk, which serves as the gold standard for infant formula development [2] - The collaboration with experts has led to the establishment of a robust maternal and infant health cohort, providing essential data for developing formulas tailored to Chinese infants [5] Group 2: Technological Innovations - Feihe has made significant advancements in preserving the active nutrients found in breast milk, focusing on fresh and live nutrition systems [6] - The company has implemented a unique technology path that allows for the direct extraction of active substances from raw milk, positioning it at a global leading level in infant formula manufacturing [6][9] Group 3: Industry Impact - The introduction of "new generation more suitable" infant formula signifies a shift in the industry from mere ingredient competition to a focus on nutritional activity and efficiency [9] - Feihe's efforts are seen as setting a new standard in the infant formula sector, aiming to provide a "Chinese solution" for global infant nutrition improvement [9][11]

Core Insights - The Chinese milk powder industry is still struggling with overall sluggishness in consumer spending despite a recovery phase after four years of price wars and market restructuring [2][3] - China Feihe, a leading domestic milk powder brand, has made a strategic adjustment by reintroducing its classic positioning of being "more suitable for Chinese babies," signaling a proactive approach to seize market opportunities during this recovery period [2][3][4] Industry Overview - The milk powder industry has been mired in price wars, with many companies sacrificing profit margins through aggressive promotions, which has negatively impacted overall profitability and hindered the high-end market development of domestic brands [3][4] - A recovery in the industry began in the second half of last year, supported by a rebound in birth rates and a collective push from domestic and foreign companies to stabilize pricing strategies [3][4] Company Strategy - On October 14, China Feihe held a large-scale launch event to unveil its "new generation more suitable" strategy and several new products, marking a significant shift in its marketing approach [3][5] - The return to the classic positioning comes after a brief period of shifting focus to a different brand message, highlighting the importance of strategic adaptability in a competitive landscape [3][4][5] Competitive Landscape - The competition in the milk powder industry is evolving from price-based competition to value-based positioning, with factors such as policy benefits, research capabilities, and comprehensive service channels becoming critical [7] - In 2024, China Feihe reported revenue of 20.749 billion yuan, a year-on-year increase of 6.2%, and a net profit of 3.57 billion yuan, reflecting resilience in a challenging market [7] Market Dynamics - The competitive differentiation is evident, with foreign brands showing strong performance in general trade and cross-border sales, while domestic brands are experiencing slower growth and a decline in market share [5][6] - China Feihe's strategic return to its classic positioning is seen as urgent to rebuild its value barriers and maintain its competitive edge against rising foreign brands [5][6] Future Outlook - The introduction of a government subsidy policy for families with children under three years old starting January 1, 2025, has triggered a "subsidy war" among leading dairy companies, with China Feihe committing 1.2 billion yuan to attract new families [7][8] - The launch of new products under the "new generation more suitable" strategy aims to target the high-end market and reactivate growth momentum in the infant formula segment [8]

Core Viewpoint - The article discusses Feihe Dairy's launch of the "New Generation More Suitable" strategy, which aims to redefine infant formula standards in China through innovations in the entire supply chain, breast-milk-like formulas, fresh nutrition, and feeding effectiveness [1][2]. Group 1: Strategic Overview - Feihe Dairy's strategy marks a significant shift in the Chinese infant formula industry from "catching up" to "keeping pace" and even "leading" in certain areas, reflecting a qualitative leap in the sector [2][4]. - The company has been deeply involved in breast milk research and has innovated across the entire production chain, emphasizing the importance of scientific breakthroughs in their strategy [2][5]. Group 2: Research and Development - Feihe's Chief Scientist revealed that the foundation of the "New Generation More Suitable" strategy is based on decoding the secrets of Chinese breast milk, with the company participating in national research programs since 2009 [5]. - The latest clinical research indicates that Feihe's Xingfeifan Zhuorui formula promotes infant growth and development similarly to breast milk, with a study involving over 600 infants showing no significant differences in developmental abilities [5]. Group 3: Product Innovation - Feihe has developed a "China Mother Source Bionic Formula" that closely aligns with the composition of Chinese breast milk, achieving a Sn-2 DHA ratio of 52.5%, which is nearly equivalent to the average level in breast milk [6]. - The company has also introduced a global unique "Fresh Nutrition System," ensuring fresh milk sources and rapid low-temperature transport to preserve nutritional quality [8][9]. Group 4: Market Position and Services - Feihe has maintained its position as the top seller in the Chinese infant formula market for six consecutive years and has ranked first globally for four years, showcasing its competitive strength [11]. - The "Star Mom Club," a platform for over 85 million Chinese mothers, provides comprehensive scientific feeding guidance, and Feihe plans to offer developmental assessment tools to assist parents in tracking their children's growth [11].